Results 251 to 260 of about 645,718 (276)

Cell‐Mediated Immunity and Antibody Responses toBordetella pertussisAntigens in Children with a History of Pertussis Infection and in Recipients of an Acellular Pertussis Vaccine [PDF]

, 2000
Clara Maria Ausiello, Roberto Lande, Francesca Urbani, Beatrice Di Carlo, Paola Stefanelli, Stefania Salmaso, Paola Mastrantonio, Antonio Cassone   +7 more
openalex   +1 more source

Development of improved pertussis vaccine

Human Vaccines & Immunotherapeutics, 2014
M. Rumbo, D. Hozbor
semanticscholar   +1 more source

Erratum to "Assessment of Pertussis Vaccine Protective Effectiveness in Children in the Amhara Regional State, Ethiopia". [PDF]

Int J Microbiol, 2020
Taye S, Tessema B, Gelaw B, Moges F.
europepmc   +1 more source

Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens [PDF]

, 2000
Elizabeth J. Ryan, Lennart Nilsson, N-I M Kjellman, Leif Gothefors, Kingston H. G. Mills   +4 more
openalex   +1 more source

Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children [PDF]

, 2000
Patrick G. Holt, Anna Rudin, Claudia Macaubas, Barbara J. Holt, Julie Rowe, Richard Loh, Peter D. Sly   +6 more
openalex   +1 more source

Acellular pertussis vaccine effectiveness for children during the 2009–2010 pertussis epidemic in Queensland

Medical Journal of Australia, 2014
S. Sheridan, B. McCall, Craig A Davis, J. Robson, B. Hull, C. Selvey, R. Ware, K. Grimwood, Stephen B Lambert   +8 more
semanticscholar   +1 more source

Protecting against Bordetella pertussis or Bordetella bronchiseptica using native, recombinant vaccine consisting of 69 kDa outer membrane protein or filamentous hemagglutinin protein purified from B. pertussis, Bordetella parapertussis or B. bronchiseptica

, 1992

openalex   +1 more source

A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine

Mucosal Immunology, 2014
A. Dunne, Lisa A. Mielke, Aideen C. Allen, Caroline E. Sutton, Rowan Higgs, Clare C. Cunningham, Sarah C. Higgins, Kingston H. G. Mills   +7 more
semanticscholar   +1 more source

Tdap Vaccine Effectiveness in Adolescents During the 2012 Washington State Pertussis Epidemic

Pediatrics, 2015
Anna M. Acosta, C. DeBolt, Azadeh Tasslimi, Melissa M Lewis, L. K. Stewart, L. Misegades, Nancy E. Messonnier, T. Clark, S. Martin, Manisha Patel   +9 more
semanticscholar   +1 more source

Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.

Lancet Glob Health
Nakabembe E, Greenland M, Amaral K, Abu-Raya B, Amone A, Andrews N, Cantrell L, Lesne E, Gorringe A, Halkerston R, Mcstraw N, Dixon L, Hunter OF, Heath PT, Imede E, Kyohere M, Musoke P, Nakimuli A, Sekikubo M, Taylor S, Tusubira V, Sadarangani M, Le Doare K.   +22 more
europepmc   +1 more source